Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Metastatic
Interventions: DRUG: Irinotecan Hydrochloride
Sponsor: MedSIR